Consumer Health

Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms

Medtronic plc (NYSE:MDT) has received CE (Conformité Européenne) Mark for the Aurora EV-ICD™ MRI SureScan™ (Extravascular Implant...

 February 18, 2023 | News

Biomimicry in Biotech: Researchers Look to Nature for Solutions to Human Health Problems

By studying and replicating natural systems, scientists are uncovering new avenues for drug development, medical device design, and even disease prevention...

 February 17, 2023 | Opinion

HanAll Biopharma Invests in Interon to Seek Collaboration Opportunities

HanAll will invest in Interon Laboratories, a preclinical-stage biotechnology company focused on treating complex neurological disorders Interon is deve...

 February 13, 2023 | News

EYLEA now approved to treat five retinal conditions caused by ocular angiogenesis

ROP is a leading cause of childhood blindness worldwide   Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug...

 February 09, 2023 | News

Tavneos® (avacopan) approved in Australia for the treatment of ANCA-associated vasculitis

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced the Therapeutic Goods Administration (TGA) in Australia has approved Tavneos&r...

 February 07, 2023 | News

BeiGene Aim to Accelerate Integration of Mental Health into Quality Cancer Care

BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, has released a report highlighting the challenges cancer patients and car...

 February 03, 2023 | News

GENE to Launch World’s First Comprehensive Risk Test for Breast & Ovarian Cancer

Combined with other clinical risk factors the test provides a comprehensive risk assessment in a simple saliva test.   Highlights: New test integ...

 February 03, 2023 | News

FDA Approves First Oral Treatment for Anemia Caused by Chronic Kidney Disease for Adults on Dialysis

"With an oral drug option in addition to the FDA-approved injection options, adults with chronic kidney disease on dialysis now have multiple ways to treat...

 February 02, 2023 | News

Sirnaomics Accelerates Clinical Development of STP705 for the Treatment of Non-Melanoma Skin Cancers

Based on positive clinical readouts from a Phase IIb study for isSCC and a Phase II study for BCC, Sirnaomics is formulating a communication package for th...

 February 02, 2023 | News

Innovation Deficit: Funds for Neglected Diseases like TB are Falling Short

The 2022 G-FINDER Report, released today, reveals that for the year 2021, global funding for the development of critical new health technologies to overcom...

 February 01, 2023 | News

Moderna Granted FDA Breakthrough Therapy Designation for Mrna-1345, an Investigational Respiratory Syncytial Virus (Rsv) Vaccine Candidate

 Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced mRNA-1345, an investig...

 January 30, 2023 | News

Lupin Launches LYFE, its Digital Therapeutic Solution for Holistic Heart Care

Designed by leading Indian cardiologists, LYFE helps patients improve their heart health through doctor-connected online and offline modules. FDA and CE ap...

 January 27, 2023 | News

Zhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer Treatment

Zhongxin launched the Program aiming to navigate and solve the medication challenges faced by cancer patients. During cancer treatment process, the use of ...

 January 20, 2023 | News

AffaMed Therapeutics to commercialize Galcanezumab for Migraine Prevention in Mainland China

AffaMed Therapeutics ("AffaMed"), a global clinical stage biopharmaceutical company dedicated to address critical unmet medical needs in neurological, psyc...

 January 17, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close